substance p has been researched along with Pulmonary Disease, Chronic Obstructive in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustyniak, D; Drulis-Kawa, Z; Gorczyca, D; Roszkowiak, J; Skała, J; Wiśniewska, I | 1 |
| Gifford, AH; Harver, A; Kraemer, WJ; Kupchak, BR; Mahler, DA; Ward, J; Waterman, LA | 1 |
| Chang, AS; Gifford, AH; Gilani, A; Hilton, J; Kraemer, WJ; Kupchak, BR; Mahler, DA; Waterman, LA | 1 |
| Dicpinigaitis, PV; Sitkauskiene, B | 1 |
| Arai, H; Orui, T; Sakaki, H; Yamaya, M | 1 |
| Bononi, I; Boschetto, P; Creminon, C; De Rosa, E; Fabbri, LM; Faggian, D; Mapp, CE; Miotto, D; Papi, A; Plebani, M | 1 |
| De Swert, KO; Joos, GF | 1 |
| Cai, L; Kang, J; Tian, L | 1 |
3 review(s) available for substance p and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Effect of smoking on cough reflex sensitivity in humans.
Topics: Action Potentials; Afferent Pathways; Animals; Calcitonin Gene-Related Peptide; Cough; Guinea Pigs; Humans; Lung; Models, Animal; Nerve Fibers, Unmyelinated; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Receptors, Nicotinic; Reflex; Smoking; Substance P | 2010 |
[Aspiration pneumonia in the elderly].
Topics: Activities of Daily Living; Aged; Cerebrovascular Disorders; Deglutition Disorders; Dental Care for Aged; Humans; Pneumonia, Aspiration; Pulmonary Disease, Chronic Obstructive; Sleep; Substance P | 2003 |
Extending the understanding of sensory neuropeptides.
Topics: Animals; Asthma; Bronchoconstriction; Clinical Trials as Topic; Disease Models, Animal; Humans; Neurokinin A; Neurons, Afferent; Neurotransmitter Agents; Pulmonary Disease, Chronic Obstructive; Receptors, Tachykinin; Respiratory System; Respiratory System Agents; Substance P | 2006 |
3 trial(s) available for substance p and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Effect of increased blood levels of β-endorphin on perception of breathlessness.
Topics: Adrenocorticotropic Hormone; Aged; beta-Endorphin; Biomarkers; Dyspnea; Female; Humans; Ketoconazole; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Receptors, Opioid; Respiratory System; Severity of Illness Index; Substance P; Treatment Outcome | 2013 |
Antagonism of substance P and perception of breathlessness in patients with chronic obstructive pulmonary disease.
Topics: Aged; Aprepitant; beta-Endorphin; Double-Blind Method; Dyspnea; Female; Humans; Male; Morpholines; Naloxone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Perception; Pulmonary Disease, Chronic Obstructive; Respiration; Substance P; Time Factors; Treatment Outcome | 2014 |
Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease.
Topics: Aged; Female; Humans; Male; Middle Aged; Neurokinin A; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Smoking; Sputum; Substance P | 2005 |
2 other study(ies) available for substance p and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Neuropeptides SP and CGRP Diminish the
Topics: A549 Cells; Antigens, CD; Calcitonin Gene-Related Peptide; Cell Adhesion Molecules; Epithelial Cells; GPI-Linked Proteins; Humans; Inflammation; Interleukin-1beta; Moraxella catarrhalis; Neutrophils; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Substance P | 2018 |
[Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
Topics: Aged; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sputum; Substance P; Vital Capacity | 2000 |